https://m2.mtmt.hu/ hun 2026-09-22 21:18 JournalArticle 32758308 VALIDATED true Second Department of Pediatrics, Semmelweis University, Budapest, Hungary First Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary Cited By :2 Export Date: 24 May 2024 CODEN: POREF Correspondence Address: Mohás, A.; Second Department of Pediatrics, Hungary; email: mohas.anna@med.semmelweis-univ.hu Correspondence Address: Csóka, M.; Second Department of Pediatrics, Hungary; email: csoka.monika@med.semmelweis-univ.hu 0 false 2026-08-27T08:38:28.226+0000 2022-11-03T12:47:08.338+0000 2022-03-25T19:55:40.045+0000 true 10019974 xSzűts xFerencné /api/admin/10019974 Admin xSzűts xFerencné (xSE_AOK_2Gyerek_Admin5_SzFné, admin) true 10019974 2026-07-29T10:13:09.110+0000 2022-11-03T12:47:08.602+0000 true 10074913 Sághi-Keszthelyi Anna /api/admin/10074913 Admin Sághi-Keszthelyi Anna (SE_KK_Admin5_SKA, admin) true true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Mohás, Anna true true /api/journal/1035680 REVIEWED PATHOLOGY AND ONCOLOGY RESEARCH 1219-4956 1532-2807 true false 1035680 false 1035680 true 1219-4956 1532-2807 Journal FOREIGN_AND_HUNGARIAN 28 1610231 1610231 11 2022 true 2022 true true true false true false NONE 2026-08-27 false 8 0 8 6 2 7 7 5 7 7 7 5 5 6 2 0 8 6 8 6 0 4 4 Folyóiratcikk Journal Article 24 8 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2023 0 2 1 2 1 2024 0 1 0 1 0 2025 0 4 4 4 4 2026 0 1 1 1 1 Q2 false false false false 2022-04-26T07:13:02.673+0000 I. Sz. Patológiai és Kísérleti Rákkutató Intézet (SE / AOK / I); II. Sz. Gyermekgyógyászati Klinika (SE / AOK / K) 8 20 2 9 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 101160279 /api/authorship/101160279 Mohás, Anna ✉ [Mohás, Anna (Gyermekgyógyászat...), szerző] II. Sz. Gyermekgyógyászati Klinika (SE / AOK / K) 1 0.111 true false true Author 10072551 /api/author/10072551 Mohás Anna (Gyermekgyógyászat gyermekonkológia) Mohás Anna true true Mohás Anna true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 101160280 /api/authorship/101160280 Krencz, Ildikó [Krencz, Ildikó (Tüdődaganatok), szerző] I. Sz. Patológiai és Kísérleti Rákkutató Intézet (SE / AOK / I) 2 0.111 false false false Author 10051986 /api/author/10051986 Krencz Ildikó (Tüdődaganatok) Krencz Ildikó true 10051986 true Krencz Ildikó true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 101160281 /api/authorship/101160281 Váradi, Zsófia [Váradi, Zsófia (Gyermekgyógyászat), szerző] II. Sz. Gyermekgyógyászati Klinika (SE / AOK / K) 3 0.111 false false false Author 10054256 /api/author/10054256 Váradi Zsófia (Gyermekgyógyászat) Váradi Zsófia true 10054256 true Váradi Zsófia true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 101160282 /api/authorship/101160282 Arató, Gabriella [Arató, Gabriella (Patológia), szerző] I. Sz. Patológiai és Kísérleti Rákkutató Intézet (SE / AOK / I) 4 0.111 false false false Author 10032348 /api/author/10032348 Arató Gabriella (Patológia) Arató Gabriella true 10032348 true Arató Gabriella true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 101160283 /api/authorship/101160283 Felkai, Luca [Felkai, Luca (gyermekgyógyászat), szerző] II. Sz. Gyermekgyógyászati Klinika (SE / AOK / K) 5 0.111 false false false Author 10061286 /api/author/10061286 Felkai Luca (gyermekgyógyászat) Felkai Luca true 10061286 true Felkai Luca true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 101160284 /api/authorship/101160284 Kiss, Dorottya Judit 6 0.11111111 false false false Kiss Dorottya Judit true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 101160285 /api/authorship/101160285 Moldvai, Dorottya [Moldvai, Dorottya (Tumorbiológia), szerző] I. Sz. Patológiai és Kísérleti Rákkutató Intézet (SE / AOK / I) 7 0.111 false false false Author 10078438 /api/author/10078438 Moldvai Dorottya (Tumorbiológia) Moldvai Dorottya true true Moldvai Dorottya true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 101160286 /api/authorship/101160286 Sebestyén, Anna [Sebestyén, Anna (Tumorbiológia), szerző] I. Sz. Patológiai és Kísérleti Rákkutató Intézet (SE / AOK / I) 8 0.111 false false false Author 10000745 /api/author/10000745 Sebestyén Anna (Tumorbiológia) Sebestyén Anna true 10000745 true Sebestyén Anna true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 101160287 /api/authorship/101160287 Csóka, Monika ✉ [Csóka, Monika (Gyermekgyógyászat...), szerző] II. Sz. Gyermekgyógyászati Klinika (SE / AOK / K) 9 0.111 false true true Author 10022998 /api/author/10022998 Csóka Monika (Gyermekgyógyászat hematológia) Csóka Monika true 10022998 true Csóka Monika true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 20818022 /api/publicationidentifier/20818022 DOI: 10.3389/pore.2022.1610231 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.3389/pore.2022.1610231 https://doi.org/10.3389/pore.2022.1610231 false true PublicationIdentifier 20908748 /api/publicationidentifier/20908748 WoS: 000780201800001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 000780201800001 https://www.webofscience.com/wos/woscc/full-record/000780201800001 true true PublicationIdentifier 20908741 /api/publicationidentifier/20908741 Scopus: 85128112609 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85128112609 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85128112609 true true PublicationIdentifier 20908742 /api/publicationidentifier/20908742 PubMed: 35392503 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 35392503 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35392503&dopt=Abstract true true Classification 12422 /api/classification/12422 Gyermekegészség true true SjrRating 11309965 /api/sjrrating/11309965 sjr:Q2 (2022) Scopus - Medicine (miscellaneous) PATHOLOGY AND ONCOLOGY RESEARCH 1219-4956 1532-2807 977 0.49 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2701 /api/classificationexternal/2701 Scopus - Medicine (miscellaneous) true 2701 true Q2 DIRECT true true Reference 29316583 /api/reference/29316583 1. Pizzo 2015: Principles and Practice of Pediatric Oncology 1 false true Reference 29316584 /api/reference/29316584 2. Smeland 2019: Survival and Prognosis with Osteosarcoma: Outcomes in More Than 2000 Patients in the EURAMOS-1 (European and American Osteosarcoma Study) Cohort., Eur J Cancer, 109, p. 36, DOI: 10.1016/j.ejca.2018.11.027 2 10.1016/j.ejca.2018.11.027 false true Reference 29316585 /api/reference/29316585 3. Coller 2014: Is Cancer a Metabolic Disease?., Am J Pathol, 184, p. 4, DOI: 10.1016/j.ajpath.2013.07.035 3 10.1016/j.ajpath.2013.07.035 false true Reference 29316586 /api/reference/29316586 4. Mossmann 2018: mTOR Signalling and Cellular Metabolism Are Mutual Determinants in Cancer., Nat Rev Cancer, 18, p. 744, DOI: 10.1038/s41568-018-0074-8 4 10.1038/s41568-018-0074-8 false true Reference 29316587 /api/reference/29316587 5. Wan 2007: The Biology behind mTOR Inhibition in Sarcoma., The Oncologist, 12, p. 1007, DOI: 10.1634/theoncologist.12-8-1007 5 10.1634/theoncologist.12-8-1007 false true Reference 29316588 /api/reference/29316588 6. Wander 2011: Next-generation mTOR Inhibitors in Clinical Oncology: How Pathway Complexity Informs Therapeutic Strategy., J Clin Invest, 121, p. 1231, DOI: 10.1172/jci44145 6 10.1172/jci44145 false true Reference 29316589 /api/reference/29316589 7. Zhou 2010: mTOR/p70S6K Signal Transduction Pathway Contributes to Osteosarcoma Progression and Patients' Prognosis., Med Oncol, 27, p. 1239, DOI: 10.1007/s12032-009-9365-y 7 10.1007/s12032-009-9365-y false true Reference 29316590 /api/reference/29316590 8. Perry 2014: Complementary Genomic Approaches Highlight the PI3K/mTOR Pathway as a Common Vulnerability in Osteosarcoma., Proc Natl Acad Sci U S A, 111, p. E5564, DOI: 10.1073/pnas.1419260111 8 10.1073/pnas.1419260111 false true Reference 29316591 /api/reference/29316591 9. Wang 2014: Targeted Inhibition of mTORC2 Prevents Osteosarcoma Cell Migration and Promotes Apoptosis., Oncol Rep, 32, p. 382, DOI: 10.3892/or.2014.3182 9 10.3892/or.2014.3182 false true Reference 29316592 /api/reference/29316592 10. Fleuren 2014: Temsirolimus Combined with Cisplatin or Bevacizumab Is Active in Osteosarcoma Models., Int J Cancer, 135, p. 2770, DOI: 10.1002/ijc.28933 10 10.1002/ijc.28933 false true Reference 29316593 /api/reference/29316593 11. Horie 2015: Apoptosis and Antitumor Effects Induced by the Combination of an mTOR Inhibitor and an Autophagy Inhibitor in Human Osteosarcoma MG63 Cells., Int J Oncol, 48, p. 37, DOI: 10.3892/ijo.2015.3227 11 10.3892/ijo.2015.3227 false true Reference 29316594 /api/reference/29316594 12. Hu 2016: mTOR Signaling in Osteosarcoma: Oncogenesis and Therapeutic Aspects (Review)., Oncol Rep, 36, p. 1219, DOI: 10.3892/or.2016.4922 12 10.3892/or.2016.4922 false true Reference 29316595 /api/reference/29316595 13. Wagner 2015: Phase II Study of Cixutumumab in Combination with Temsirolimus in Pediatric Patients and Young Adults with Recurrent or Refractory Sarcoma: A Report from the Children's Oncology Group., Pediatr Blood Cancer, 62, p. 440, DOI: 10.1002/pbc.25334 13 10.1002/pbc.25334 false true Reference 29316596 /api/reference/29316596 14. Whelan 2015: EURAMOS-1, an International Randomised Study for Osteosarcoma: Results from Pre-randomisation Treatment., Ann Oncol, 26, p. 407, DOI: 10.1093/annonc/mdu526 14 10.1093/annonc/mdu526 false true Reference 29316597 /api/reference/29316597 15. Adamo 2011: Phosphatidylinositol 3-kinase Pathway Activation in Breast Cancer Brain Metastases., Breast Cancer Res, 13, p. 125, DOI: 10.1186/bcr3071 15 10.1186/bcr3071 false true Reference 29316598 /api/reference/29316598 16. Krencz 2017: Expression of mTORC1/2-Related Proteins in Primaryand Brain Metastatic Lung Adenocarcinoma., Hum Pathol, 62, p. 66, DOI: 10.1016/j.humpath.2016.12.012 16 10.1016/j.humpath.2016.12.012 false true Reference 29316599 /api/reference/29316599 17. Ottaviani 2009: The Epidemiology of Osteosarcoma., Cancer Trear Res, 152, p. 3, DOI: 10.1007/978-1-4419-0284-9_1 17 10.1007/978-1-4419-0284-9_1 false true Reference 29316600 /api/reference/29316600 18. Zhu 2015: Activity of the Novel Dual Phosphatidylinositol 3-kinase/mammalian Target of Rapamycin Inhibitor NVP-Bez235 against Osteosarcoma., Canc Biol Ther, p. 602, DOI: 10.1080/15384047.2015.1017155 18 10.1080/15384047.2015.1017155 false true Reference 29316601 /api/reference/29316601 19. Hu 2018: The Anti-osteosarcoma Cell Activity by a mTORC1/2 Dual inhibitorRES-529., Biochem Biophysical Res Commun, 497, p. 499, DOI: 10.1016/j.bbrc.2018.02.050 19 10.1016/j.bbrc.2018.02.050 false true Reference 29316602 /api/reference/29316602 20. Gazouli 2021: Systematic Review of Recurrent Osteosarcoma Systemic Therapy., Cancers, 13, p. 1757, DOI: 10.3390/cancers13081757 20 10.3390/cancers13081757 false true Reference 29316603 /api/reference/29316603 21. Grignani 2015: Sorafenib and Everolimus for Patients with Unresectable High-Grade Osteosarcoma Progressing after Standard Treatment: a Non-randomised Phase 2 Clinical Trial., Lancet Oncol, 16, p. 98, DOI: 10.1016/s1470-2045(14)71136-2 21 10.1016/s1470-2045(14)71136-2 false true Reference 29316604 /api/reference/29316604 22. Martin-Broto 2017: Gemcitabine Plus Sirolimus for Relapsed and Progressing Osteosarcoma Patients after Standard Chemotherapy: a Multicenter, Single-Arm Phase II Trial of Spanish Group for Research on Sarcoma (GEIS)., Ann Oncol, 28, p. 2994, DOI: 10.1093/annonc/mdx536 22 10.1093/annonc/mdx536 false true Reference 29316605 /api/reference/29316605 23. Wan 2005: Rapamycin Inhibits Ezrin-Mediated Metastatic Behavior in a Murine Model of Osteosarcoma., Cancer Res, 65, p. 2406, DOI: 10.1158/0008-5472.can-04-3135 23 10.1158/0008-5472.can-04-3135 false true Reference 29316606 /api/reference/29316606 24. Krencz 2017: Expression of mTORC1/2-Related Proteins in Primary and Brain Metastatic Lung Adenocarcinoma., Hum Pathol, 62, p. 66, DOI: 10.1016/j.humpath.2016.12.012 24 10.1016/j.humpath.2016.12.012 false true Reference 29316607 /api/reference/29316607 25. Hegyi 2011: Good Prognosis of Localized Osteosarcoma in Young Patients Treated with Limb-Salvage Surgery and Chemotherapy., Pediatr Blood Cancer, 57, p. 415, DOI: 10.1002/pbc.23172 25 10.1002/pbc.23172 false true Reference 29316608 /api/reference/29316608 26. Spraker-Perlman 2019: Factors Influencing Survival after Recurrence in Osteosarcoma: A Report from the Children’s Oncology Group., Pediatr Blood Cancer, 66, p. e27444, DOI: 10.1002/pbc.27444 26 10.1002/pbc.27444 false true Reference 29316609 /api/reference/29316609 27. Kennedy 2016: The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging., Cell Metab. ., 23, p. 990, DOI: 10.1016/j.cmet.2016.05.009 27 10.1016/j.cmet.2016.05.009 false true Reference 29316610 /api/reference/29316610 28. Saxton 2017: mTOR Signaling in Growth, Metabolism, and Disease., Cell, 169, p. 361, DOI: 10.1016/j.cell.2017.03.035 28 10.1016/j.cell.2017.03.035 false true Reference 29316611 /api/reference/29316611 29. Pavlova 2016: The Emerging Hallmarks of Cancer Metabolism., Cell Metab, 23, p. 27, DOI: 10.1016/j.cmet.2015.12.006 29 10.1016/j.cmet.2015.12.006 false true Reference 29316612 /api/reference/29316612 30. Mizushima 2020: Osteosarcoma-initiating Cells Show High Aerobic Glycolysis and Attenuation of Oxidative Phosphorylation Mediated by LIN28B., Cancer Sci, 111, p. 36, DOI: 10.1111/cas.14229 30 10.1111/cas.14229 false true Reference 29316613 /api/reference/29316613 31. Giang 2013: Mitochondrial Dysfunction and Permeability Transition inOsteosarcoma Cells Showing the Warburg Effect., J Biol Chem, 288, p. 33303, DOI: 10.1074/jbc.m113.507129 31 10.1074/jbc.m113.507129 false true Reference 29316614 /api/reference/29316614 32. Bonuccelli 2017: Role of Mesenchymal Stem Cells in Osteosarcoma and Metabolic Reprogramming of Tumor Cells., Oncotarget, 5, p. 7575, DOI: 10.18632/oncotarget.2243 32 10.18632/oncotarget.2243 false true Reference 29316615 /api/reference/29316615 33. Wang 2012: Overexpression of G6PD Is Associated with Poor Clinical Outcome in Gastric Cancer., Tumour Biol, 33, p. 95, DOI: 10.1007/s13277-011-0251-9 33 10.1007/s13277-011-0251-9 false true Reference 29316616 /api/reference/29316616 34. Fan 2008: Rhabdomyosarcoma Cells Show an Energy Producing Anabolic Metabolic Phenotype Compared with Primary Myocytes., Mol Cancer, 7, p. 79, DOI: 10.1186/1476-4598-7-79 34 10.1186/1476-4598-7-79 false true Reference 29316617 /api/reference/29316617 35. Wang 2020: LncRNA OR3A4 Regulated the Growth of Osteosarcoma Cells by Modulating the miR-1207- 5p/G6PD Signaling., OncoTargets Ther, 13, p. 3117, DOI: 10.2147/ott.s234514 35 10.2147/ott.s234514 false true Reference 29316618 /api/reference/29316618 36. Altman 2016: From Krebs to Clinic: Glutamine Metabolism to Cancer Therapy., Nat Rev Cancer, 16, p. 619, DOI: 10.1038/nrc.2016.71 36 10.1038/nrc.2016.71 false true Reference 29316619 /api/reference/29316619 37. Ren 2020: Glutaminase-1 (GLS1) Inhibition Limits Metastatic Progression in Osteosarcoma., Cancer Metab, 8, p. 4, DOI: 10.1186/s40170-020-0209-8 37 10.1186/s40170-020-0209-8 false true Reference 29316620 /api/reference/29316620 38. Beloribi-Djefaflia 2016: Lipid Metabolic Reprogramming in Cancer Cells., Oncogenesis, 5, p. e189, DOI: 10.1038/oncsis.2015.49 38 10.1038/oncsis.2015.49 false true Reference 29316621 /api/reference/29316621 39. Tan 2018: Targeting CPT1A-Mediated Fatty Acid Oxidation Sensitizes Nasopharyngeal Carcinoma to Radiation Therapy., Theranostics, 8, p. 2329, DOI: 10.7150/thno.21451 39 10.7150/thno.21451 false true Reference 29316622 /api/reference/29316622 40. Alo 2007: Immunohistochemical Expression and Prognostic Significance of Fatty Acid Synthase in Pancreatic Carcinoma., Anticancer Res, 27, p. 2523 40 false true Reference 29316623 /api/reference/29316623 41. Orita 2008: Inhibiting Fatty Acid Synthase for Chemoprevention of Chemically Induced Lung Tumors., Clin Cancer Res, 14, p. 2458, DOI: 10.1158/1078-0432.ccr-07-4177 41 10.1158/1078-0432.ccr-07-4177 false true Reference 29316624 /api/reference/29316624 42. Chen 2017: Blocking Fatty Acid Synthase Inhibits Tumor Progression of Human Osteosarcoma by Regulating the Human Epidermal Growth Factor Receptor 2/phosphoinositide 3-kinase/protein Kinase B Signaling Pathway in Xenograft Models., Exp Ther Med, 13, p. 2411, DOI: 10.3892/etm.2017.4284 42 10.3892/etm.2017.4284 false true Reference 29316625 /api/reference/29316625 43. Liu 2012: Fatty Acid Synthase Expression in Osteosarcoma and its Correlation with Pulmonary Metastasis., Oncol Lett, 4, p. 878, DOI: 10.3892/ol.2012.862 43 10.3892/ol.2012.862 false true Reference 29316626 /api/reference/29316626 44. Felkai 2020: Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma., Cancers, 12, p. 1947, DOI: 10.3390/cancers12071947 44 10.3390/cancers12071947 false true /api/publication/32758308 Mohás Anna et al. In Situ Analysis of mTORC1/C2 and Metabolism-Related Proteins in Pediatric Osteosarcoma. (2022) PATHOLOGY AND ONCOLOGY RESEARCH 1219-4956 1532-2807 28<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10072551"><a href="/gui2/?type=authors&mode=browse&sel=10072551" target="_blank">Mohás Anna ✉ (<span class="authorship-author-name">Mohás Anna</span> <span class="authorAux-mtmt"> Gyermekgyógyászat gyermekonkológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/II. Sz. Gyermekgyógyászati Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10051986"><a href="/gui2/?type=authors&mode=browse&sel=10051986" target="_blank">Krencz Ildikó (<span class="authorship-author-name">Krencz Ildikó</span> <span class="authorAux-mtmt"> Tüdődaganatok</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/I. Sz. Patológiai és Kísérleti Rákkutató Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10054256"><a href="/gui2/?type=authors&mode=browse&sel=10054256" target="_blank">Váradi Zsófia (<span class="authorship-author-name">Váradi Zsófia</span> <span class="authorAux-mtmt"> Gyermekgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/II. Sz. Gyermekgyógyászati Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10032348"><a href="/gui2/?type=authors&mode=browse&sel=10032348" target="_blank">Arató Gabriella (<span class="authorship-author-name">Arató Gabriella</span> <span class="authorAux-mtmt"> Patológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/I. Sz. Patológiai és Kísérleti Rákkutató Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10061286"><a href="/gui2/?type=authors&mode=browse&sel=10061286" target="_blank">Felkai Luca (<span class="authorship-author-name">Felkai Luca</span> <span class="authorAux-mtmt"> gyermekgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/II. Sz. Gyermekgyógyászati Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Kiss Dorottya Judit </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10078438"><a href="/gui2/?type=authors&mode=browse&sel=10078438" target="_blank">Moldvai Dorottya (<span class="authorship-author-name">Moldvai Dorottya</span> <span class="authorAux-mtmt"> Tumorbiológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/I. Sz. Patológiai és Kísérleti Rákkutató Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10000745"><a href="/gui2/?type=authors&mode=browse&sel=10000745" target="_blank">Sebestyén Anna (<span class="authorship-author-name">Sebestyén Anna</span> <span class="authorAux-mtmt"> Tumorbiológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/I. Sz. Patológiai és Kísérleti Rákkutató Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10022998"><a href="/gui2/?type=authors&mode=browse&sel=10022998" target="_blank">Csóka Monika ✉ (<span class="authorship-author-name">Csóka Monika</span> <span class="authorAux-mtmt"> Gyermekgyógyászat hematológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/II. Sz. Gyermekgyógyászati Klinika</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;32758308" target="_blank">In Situ Analysis of mTORC1/C2 and Metabolism-Related Proteins in Pediatric Osteosarcoma</a></div> <div> <span class="journal-title">PATHOLOGY AND ONCOLOGY RESEARCH</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1219-4956">1219-4956</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1532-2807">1532-2807</a>)</span>: <span class="journal-volume">28</span> <span class="page"> Paper 1610231. 11 p. </span> <span class="year">(2022)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.3389/pore.2022.1610231" target="_blank" href="https://doi.org/10.3389/pore.2022.1610231"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000780201800001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000780201800001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85128112609" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85128112609"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="35392503" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35392503&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Pathology and Forensic Medicine&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Cancer Research&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q3</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Oncology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q3</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 8</span> | Független: 6 | Függő: 2 | Nem jelölt: 0 | WoS jelölt: 5 | Scopus jelölt:&nbsp;7 | WoS/Scopus jelölt:&nbsp;7 | DOI jelölt:&nbsp;7 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;32758308&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 4 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 32758308</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="lastModified">Utolsó módosítás: 2022.11.03. 13:47 Sághi-Keszthelyi Anna (SE_KK_Admin5_SKA, admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: Second Department of Pediatrics, Semmelweis University, Budapest, Hungary First Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary Cited By :2 Export Date: 24 May 2024 CODEN: POREF Correspondence Address: Mohás, A.; Second Depart...</pre> </div></div>